Laura Mauri

Laura Mauri

UNVERIFIED PROFILE

Are you Laura Mauri?   Register this Author

Register author
Laura Mauri

Laura Mauri

Publications by authors named "Laura Mauri"

Are you Laura Mauri?   Register this Author

100Publications

2314Reads

-Profile Views

GM1 promotes TrkA-mediated neuroblastoma cell differentiation by occupying a plasma membrane domain different from TrkA.

J Neurochem 2019 Apr 26;149(2):231-241. Epub 2019 Mar 26.

Department of Medical Biotechnology and Translational Medicine, University of Milano, Milano, Italy.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/jnc.14685
Publisher Site
http://dx.doi.org/10.1111/jnc.14685DOI Listing
April 2019

Chemical and Physicochemical Properties of Gangliosides.

Methods Mol Biol 2018 ;1804:1-17

Department of Medical Biotechnology and Translational Medicine, The Medical School, University of Milano, Milano, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-4939-8552-4_1DOI Listing
March 2019

Nuclear Magnetic Resonance of Gangliosides.

Methods Mol Biol 2018 ;1804:241-284

Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-4939-8552-4_12DOI Listing
March 2019

Radioactive Gangliosides for Biological Studies.

Methods Mol Biol 2018 ;1804:311-322

Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-4939-8552-4_15DOI Listing
March 2019

Sphingolipids and neuronal degeneration in lysosomal storage disorders.

J Neurochem 2019 Mar 16;148(5):600-611. Epub 2018 Aug 16.

Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jnc.14540DOI Listing
March 2019

Validating the use of registries and claims data to support randomized trials: Rationale and design of the Extending Trial-Based Evaluations of Medical Therapies Using Novel Sources of Data (EXTEND) Study.

Am Heart J 2019 Mar 6;212:64-71. Epub 2019 Mar 6.

Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology; Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Boston, MA; Harvard Medical School, Boston, MA; Baim Institute for Clinical Research, Boston, MA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ahj.2019.02.007DOI Listing
March 2019

Gangliosides in Membrane Organization.

Prog Mol Biol Transl Sci 2018 28;156:83-120. Epub 2018 Mar 28.

University of Milano, Milano, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/bs.pmbts.2017.12.007DOI Listing
February 2019

Will SPYRAL HTN-OFF MED change my practice? SPYRAL HTN-OFF MED: a prospective, randomised, sham-controlled trial on renal denervation in the absence of antihypertensive medications.

EuroIntervention 2018 Aug 3;14(5):e603-e606. Epub 2018 Aug 3.

Klinik für Innere Medizin III, Kardiologie, Angiologie und Internistische Intensivmedizin, Universitätsklinikum des Saarlandes, Universität des Saarlandes, Homburg/Saar, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4244/EIJY18M07_2DOI Listing
August 2018

Neuronal membrane dynamics as fine regulator of sphingolipid composition.

Glycoconj J 2018 08 25;35(4):397-402. Epub 2018 Aug 25.

Department of Medical Biotechnology and Translational Medicine, University of Milano, Via Fratelli Cervi 93, 20090, Segrate, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10719-018-9841-8DOI Listing
August 2018

Benefit and Risk of Prolonged DAPT After Coronary Stenting in Women.

Circ Cardiovasc Interv 2018 Aug;11(8):e005308

Department of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA (N.C.B., L.M.).

View Article

Download full-text PDF

Source
https://www.ahajournals.org/doi/10.1161/CIRCINTERVENTIONS.11
Publisher Site
http://dx.doi.org/10.1161/CIRCINTERVENTIONS.117.005308DOI Listing
August 2018

Assignment by Negative-Ion Electrospray Tandem Mass Spectrometry of the Tetrasaccharide Backbones of Monosialylated Glycans Released from Bovine Brain Gangliosides.

J Am Soc Mass Spectrom 2018 Jun 11;29(6):1308-1318. Epub 2018 May 11.

Glycosciences Laboratory, Department of Medicine, Imperial College London, Hammersmith Campus, London, W12 0NN, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13361-018-1944-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6003998PMC
June 2018

On the use of cholera toxin.

Glycoconj J 2018 04 7;35(2):161-163. Epub 2018 Apr 7.

Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10719-018-9818-7DOI Listing
April 2018

Bioresorbable polymer drug-eluting stents - Authors' reply.

Lancet 2018 03;391(10124):936-937

Division of Interventional Cardiology, MedStar Cardiovascular Research Network, MedStar Washington Hospital Center, Washington, DC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(18)30535-XDOI Listing
March 2018

A multinational clinical approach to assessing the effectiveness of catheter-based ultrasound renal denervation: The RADIANCE-HTN and REQUIRE clinical study designs.

Am Heart J 2018 Jan 12;195:115-129. Epub 2017 Sep 12.

Université Paris-Descartes, Paris, France; AP-HP, Hôpital Européen Georges-Pompidou, Hypertension Department and DHU PARC, Paris, France; INSERM, CIC1418, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ahj.2017.09.006DOI Listing
January 2018

Impact of Clopidogrel Therapy on Mortality and Cancer in Patients With Cardiovascular and Cerebrovascular Disease: A Patient-Level Meta-Analysis.

Circ Cardiovasc Interv 2018 Jan;11(1):e005795

From the Cardiology Division, Department of Medicine, Massachusetts General Hospital (S.E.), Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital (D.L.B., L.M.), Smith Center for Outcomes Research in Cardiology, Department of Medicine, Beth-Israel Deaconess Medical Center (R.W.Y.), Harvard Medical School, Boston, MA (S.E., D.L.B., R.W.Y., L.M.); Baim Institute for Clinical Research, Boston, MA (S.E., G.D., Y.L., W.-H.H., R.W.Y., L.M.); Department of Biostatistics, Boston University School of Public Health, MA (G.D.); University of British Columbia, Vancouver, Canada (O.R.B.); Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada (S.J.C., S.Y.); and Scripps Translational Science Institute, La Jolla, CA (S.R.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCINTERVENTIONS.117.005795DOI Listing
January 2018

Noninferiority Trials.

N Engl J Med 2018 01;378(3):304-305

Boston University, Boston, MA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1714668DOI Listing
January 2018

Rationale of a novel study design for the BIOFLOW V study, a prospective, randomized multicenter study to assess the safety and efficacy of the Orsiro sirolimus-eluting coronary stent system using a Bayesian approach.

Am Heart J 2017 Nov 5;193:35-45. Epub 2017 Aug 5.

Baim Institute for Clinical Research, Boston, MA; Brigham and Women's Hospital, Boston, MA; Harvard Medical School, Boston, MA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ahj.2017.08.001DOI Listing
November 2017

Challenges in the Design and Interpretation of Noninferiority Trials.

N Engl J Med 2017 Oct;377(14):1357-1367

From the Division of Cardiovascular Medicine, Brigham and Women's Hospital (L.M.), Harvard Medical School (L.M.), the Department of Mathematics and Statistics, Boston University (R.B.D.), and Baim Institute for Clinical Research (L.M., R.B.D.) - all in Boston.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMra1510063DOI Listing
October 2017

Lesion Complexity and Outcomes of Extended Dual Antiplatelet Therapy After Percutaneous Coronary Intervention.

J Am Coll Cardiol 2017 Oct;70(18):2213-2223

Baim Institute for Clinical Research, Boston, Massachusetts; Brigham and Women's Hospital, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacc.2017.09.011DOI Listing
October 2017

Practice Patterns and In-Hospital Outcomes Associated With Bivalirudin Use Among Patients With Non-ST-Segment-Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention in the United States.

Circ Cardiovasc Qual Outcomes 2017 Sep;10(9)

From the Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Boston (E.A.S.); Harvard Medical School, Boston, MA (E.A.S., E.G.F., L.M., R.W.Y.); Smith Center for Outcomes Research in Cardiology; Beth Israel Deaconess Medical Center, Boston, MA (E.A.S., R.W.Y.); Division of Cardiology, Department of Medicine, Center for Interventional Vascular Therapy, New York, NY (A.K.); Columbia University, New York, NY (A.K.); Division of Cardiology, Department of Medicine, New York University School of Medicine (S.B.); Division of Cardiology, Department of Medicine, Virginia Commonwealth University, Richmond, VA (I.S.J., D.P.); Division of Cardiology, Department of Medicine; Christiana Care Health System, Newark, DE (N.J.W.); Duke Clinical Research Institute, Duke University, Durham, NC (M.R., D.D.); and Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA (L.M.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCOUTCOMES.117.003741DOI Listing
September 2017

Usefulness of Intracoronary Brachytherapy for Patients With Resistant Drug-Eluting Stent Restenosis.

Am J Cardiol 2017 Aug 10;120(3):369-373. Epub 2017 May 10.

Brigham and Women's Hospital Heart & Vascular Center and Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjcard.2017.04.036DOI Listing
August 2017

Update on antithrombotic therapy after percutaneous coronary revascularisation.

Lancet 2017 Aug;390(10096):810-820

Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA, USA; Baim Institute for Clinical Research, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(17)31936-0DOI Listing
August 2017

Myocardial Infarction Risk After Discontinuation of Thienopyridine Therapy in the Randomized DAPT Study (Dual Antiplatelet Therapy).

Circulation 2017 May 22;135(18):1720-1732. Epub 2017 Feb 22.

From Massachusetts General Hospital, Boston (A.C.S.S.); Baim Institute for Clinical Research (formerly Harvard Clinical Research Institute), Boston, MA (A.C.S.S., D.E.C., R.W.Y., R.B.D'A., J.M.M., W.-H.H., L.M.); Brigham and Women's Hospital, Boston, MA (A.C.S.S., L.M.); Christ Hospital, Heart and Vascular Center and Lindner Center for Research and Education, Cincinnati, OH (D.J.K.); and Beth Israel Deaconess Medical Center, Boston, MA (D.E.C., R.W.Y.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.116.024835DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5469374PMC
May 2017

Mortality Following Cardiovascular and Bleeding Events Occurring Beyond 1 Year After Coronary Stenting: A Secondary Analysis of the Dual Antiplatelet Therapy (DAPT) Study.

JAMA Cardiol 2017 May;2(5):478-487

Harvard Medical School, Boston, Massachusetts 3Center for Clinical Biometrics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts 5Baim Institute for Clinical Research, Boston, Massachusetts 14Division of Cardiology, Brigham and Women's Hospital, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamacardio.2017.0063DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5814981PMC
May 2017

Extended Duration Dual Antiplatelet Therapy After Coronary Stenting Among Patients With Peripheral Arterial Disease: A Subanalysis of the Dual Antiplatelet Therapy Study.

JACC Cardiovasc Interv 2017 05;10(9):942-954

Division of Cardiology and Center for Clinical Biometrics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts; Baim Institute for Clinical Research, Boston, Massachusetts. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S19368798173032
Publisher Site
http://dx.doi.org/10.1016/j.jcin.2017.02.013DOI Listing
May 2017

Altered expression of ganglioside GM3 molecular species and a potential regulatory role during myoblast differentiation.

J Biol Chem 2017 04 8;292(17):7040-7051. Epub 2017 Mar 8.

From the Division of Glycopathology, Institute of Molecular Biomembrane and Glycobiology, Tohoku Medical and Pharmaceutical University, Sendai 981-8558, Japan,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M116.771253DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5409471PMC
April 2017

Response by Resor and Mauri to Letter Regarding Article, "Impact of Optimal Medical Therapy in the Dual Antiplatelet Therapy Study".

Circulation 2017 04;135(14):e866

From Division of Cardiology and Center for Clinical Biometrics, Department of Medicine, Brigham and Women's Hospital, Boston, MA (C.D.R., L.M.); and Harvard Medical School, Boston, MA (L.M.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.117.027319DOI Listing
April 2017

Serum Antibodies to Glycans in Peripheral Neuropathies.

Mol Neurobiol 2017 03 11;54(2):1564-1567. Epub 2016 Feb 11.

Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12035-016-9775-8DOI Listing
March 2017

T Follicular Helper Cells Promote a Beneficial Gut Ecosystem for Host Metabolic Homeostasis by Sensing Microbiota-Derived Extracellular ATP.

Cell Rep 2017 03;18(11):2566-2575

Institute for Research in Biomedicine, Università della Svizzera Italiana, 6500 Bellinzona, Switzerland; Department of Medical Biotechnology and Translational Medicine (BIOMETRA), Università degli Studi di Milano, 20129 Milan, Italy; Istituto Nazionale Genetica Molecolare "Romeo ed Enrica Invernizzi," 20122 Milan, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.celrep.2017.02.061DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5368345PMC
March 2017

Long-Term Outcomes of Stenting the Proximal Left Anterior Descending Artery in the PROTECT Trial.

JACC Cardiovasc Interv 2017 03;10(6):548-556

Cardiovascular Research Center, OLV Hospital, Aalst, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2016.12.028DOI Listing
March 2017

5-Year Safety and Efficacy of Resolute Zotarolimus-Eluting Stent: The RESOLUTE Global Clinical Trial Program.

JACC Cardiovasc Interv 2017 02 18;10(3):247-254. Epub 2017 Jan 18.

Division of Cardiovascular Medicine, Baim Institute for Clinical Research, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2016.11.004DOI Listing
February 2017

Use and Effectiveness of Bivalirudin Versus Unfractionated Heparin for Percutaneous Coronary Intervention Among Patients With ST-Segment Elevation Myocardial Infarction in the United States.

JACC Cardiovasc Interv 2016 12 9;9(23):2376-2386. Epub 2016 Nov 9.

Harvard Medical School, Boston, Massachusetts; Smith Center for Outcomes Research in Cardiology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2016.09.020DOI Listing
December 2016

Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2016 Update.

Circ Cardiovasc Interv 2016 11;9(11)

From the Division of Cardiology, University of Florida College of Medicine-Jacksonville (D.J.A.); St Michael's Hospital, University of Toronto, and the Canadian Heart Research Centre; Canadian VIGOUR Centre, University of Alberta, Edmonton (S.G.G.); Brigham and Women's Hospital Heart & Vascular Center and Harvard Medical School, Boston, MA (D.L.B., D.P.F.); Department of Medicine, Population Health Research Institute, Thrombosis & Atherosclerosis Research Institute, Hamilton, ON, Canada (J.W.E.); Division of Cardiovascular Diseases, Scripps Clinic, La Jolla CA (M.J.P.); Division of Cardiovascular Medicine and Gill Heart Institute, University of Kentucky, Lexington (D.J.M.); Brigham and Women's Hospital, Harvard Clinical Research Institute, Harvard Medical School, Boston, MA (C.P.C., L.M.); Department of Medicine, Montreal Heart Institute, Université de Montréal, QC, Canada (J.-F.T.); Duke Clinical Research Institute, Duke University, Durham, NC (C.B.G.); Mayo Clinic, Rochester, MN (D.R.H.); and Division of Cardiology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA (C.M.G.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCINTERVENTIONS.116.004395DOI Listing
November 2016

Frequency of Stent Thrombosis Risk at 5 Years in Women Versus Men With Zotarolimus-Eluting Compared With Sirolimus-Eluting Stent.

Am J Cardiol 2016 Oct 29;118(8):1178-1186. Epub 2016 Jul 29.

Department of Cardiology, Erasmus MC, Rotterdam, The Netherlands; Cardiovascular research school COEUR, Erasmus MC, Rotterdam, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjcard.2016.07.032DOI Listing
October 2016

Impact of Optimal Medical Therapy in the Dual Antiplatelet Therapy Study.

Circulation 2016 Oct 30;134(14):989-998. Epub 2016 Aug 30.

From Division of Cardiology and Center for Clinical Biometrics, Department of Medicine, Brigham and Women's Hospital, Boston, MA (C.D.R., L.M.); Harvard Clinical Research Institute, Boston, MA (R.W.Y., D.E.C., W.-H.H., L.M.); Harvard Medical School, Boston, MA (R.W.Y., L.M.); Division of Cardiology, University of Pennsylvania Medical Center, Philadelphia (A.N.); Smith Center for Outcomes Research in Cardiology, Beth Israel Deaconess Medical Center, Boston, MA (R.W.Y., D.E.C.); Department of Biostatistics, Boston University School of Public Heath, MA (J.M.M.); The Christ Hospital Heart and Vascular Center and The Lindner Center for Research and Education, Cincinnati, OH (D.J.K.); Université Paris-Diderot, INSERM U-1148, Hôpital Bichat, Département Hospitalo-Universitaire Fibrosis, Inflammation, and Remodeling, Assistance Publique-Hôpitaux de Paris, Paris, France (P.G.S.); and National Heart and Lung Institute, Institute of Cardiovascular Medicine and Science, Royal Brompton Hospital, Imperial College, London, UK (P.G.S.).

View Article

Download full-text PDF

Source
https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.116.0
Publisher Site
http://dx.doi.org/10.1161/CIRCULATIONAHA.116.024531DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5421387PMC
October 2016

Lipoarabinomannan binding to lactosylceramide in lipid rafts is essential for the phagocytosis of mycobacteria by human neutrophils.

Sci Signal 2016 10 11;9(449):ra101. Epub 2016 Oct 11.

Laboratory of Biochemistry, Juntendo University Faculty of Health Care and Nursing, Urayasu, Chiba 279-0023, Japan. Institute for Environmental and Gender-Specific Medicine, Juntendo University Graduate School of Medicine, Urayasu, Chiba 279-0021, Japan. Infection Control Nursing, Juntendo University Graduate School of Health Care and Nursing, Urayasu, Chiba 279-0023, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1126/scisignal.aaf1585DOI Listing
October 2016

2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery.

Circulation 2016 Sep 29;134(10):e123-55. Epub 2016 Mar 29.

Focused Update writing group members are required to recuse themselves from voting on sections to which their specific relationships with industry may apply; see Appendix 1 for detailed information. ACC/AHA Task Force on Clinical Practice Guidelines Liaison. ACC/AHA Representative. Evidence Review Committee Chair. American Society of Anesthesiologists/Society of Cardiovascular Anesthesiologists Representative. American Association for Thoracic Surgery/Society of Thoracic Surgeons Representative. Society for Cardiovascular Angiography and Interventions Representative.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIR.0000000000000404DOI Listing
September 2016

Comparing Inverse Probability of Treatment Weighting and Instrumental Variable Methods for the Evaluation of Adenosine Diphosphate Receptor Inhibitors After Percutaneous Coronary Intervention.

JAMA Cardiol 2016 Sep;1(6):655-65

Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina8Division of Cardiology, Department of Medicine, Duke University Medical Center, Durham, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamacardio.2016.1783DOI Listing
September 2016

Focused Update on Duration of Dual Antiplatelet Therapy for Patients With Coronary Artery Disease.

JAMA Cardiol 2016 09;1(6):733-4

University of North Carolina School of Medicine, Chapel Hill, North Carolina4University of North Carolina Center for Heart and Vascular Care, Chapel Hill, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamacardio.2016.2171DOI Listing
September 2016

Prevention of Stroke with Ticagrelor in Patients with Prior Myocardial Infarction: Insights from PEGASUS-TIMI 54 (Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin-Thrombolysis in Myocardial Infarction 54).

Circulation 2016 Sep 30;134(12):861-71. Epub 2016 Aug 30.

From TIMI Study Group, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (M.P.B., D.L.B., E.G., D.A.M., E.B., M.S.); Tokai University School of Medicine; Institute of Medical Science, Isehara, Japan (S.G.); FACT, DHU-FIRE INSERM Unité 1148, Assistance Publique-Hôpitaux de Paris and Université Paris Diderot, Paris, France, and NHLI Imperial College, Royal Brompton Hospital, London, UK (P.G.S.); University of Sheffield, United Kingdom (R.F.S.); Division of Cardiology, Newark Beth Israel Medical Center, Rutgers-New Jersey Medical School, Newark (M.C.); Brigham and Women's Hospital and Harvard Clinical Research Institute, Harvard Medical School, Boston, MA (L.M.); CWZ Hospital, Nijmegen, The Netherlands (T.O.O.); Cardiology Research and Production complex MH RF, Moscow, Russia (M.R.); Internal Cardiology Department, University Hospital and Medical faculty, Brno, Czech Republic (J.S.); Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea (K.-B.S.); Heart Institute, Intervention Center, People Hospital of Peking University, China (D.H.); Life Fourways Hospital, Randburg, South Africa (A.J.D.); and AstraZeneca, Mölndal, Sweden (E.J., P.H.).

View Article

Download full-text PDF

Source
https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.116.0
Publisher Site
http://dx.doi.org/10.1161/CIRCULATIONAHA.116.024637DOI Listing
September 2016

Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure: Rationale and Design of the Randomized Trial to REDUCE Elevated Left Atrial Pressure in Heart Failure (REDUCE LAP-HF I).

Circ Heart Fail 2016 07;9(7)

From the NorthShore University Health System, Evanston Hospital, IL (T.F.); Corvia Medical Incorporated, Tewksbury, MA (J.K.); Columbia University Medical Center, New York Presbyterian Hospital, New York City, NY (D.B., M.S.M., M.B.L.); Harvard Clinical Research Institute, Boston University School of Public Health, MA (J.M.); Alfred Hospital and Baker IDI Heart and Diabetes Institute Melbourne, Australia (D.K.); Hospital of the University of Pennsylvania, Philadelphia (F.E.S.); National Heart and Lung Institute, Royal Brompton and Harefield Hospitals, Imperial College, London (J.G.F.C.); Wake Forest School of Medicine, Winston-Salem, NC (D.K.); University of Minnesota, Minneapolis (S.H.K.); University Medical Center Groningen, University of Groningen, The Netherlands (D.J.V.V.); Cardio Centrum Berlin, Academic Teaching Institution, Charité University Medicine Berlin, Germany (F.K.); Université de Nantes, Institut du thorax, Centre Hospitalier Universitaire Nantes, France (J.-N.T.); Division of Cardiology, Fondazione Cardiocentro Ticino, Lugano, Switzerland (A.A.); Department of Cardiology, Rigshospitalet, Copenhagen, Denmark (F.G.); August Universität, Gottingen, Germany (G.H.); Department of Cardiac Diseases, Military Hospital, Medical University, Wroclaw, Poland (P.P.); National and Kapodistian University of Athens, School of Medicine, Attikon University Hospital, Greece (G.F.); Division of Cardiology, Harvard Clinical Research Institute, Brigham and Women's Hospital, Boston, MA (L.M.); and Division of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL (S.J.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCHEARTFAILURE.116.003025DOI Listing
July 2016

Acute Coronary Syndrome in a 52-Year-Old Woman With Scleroderma.

Circulation 2016 Jun;133(24):2576-82

From Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA (E.T.C., L.M., C.M.); and Cardiovascular Division, University of Nebraska Medical Center, Omaha (Y.S.C.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.116.022288DOI Listing
June 2016

2015 ACC/AHA/SCAI focused update on primary percutaneous coronary intervention for patients with ST-elevation myocardial Infarction: An update of the 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention and the 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Society for Cardiovascular Angiography and Interventions.

Catheter Cardiovasc Interv 2016 May;87(6):1001-19

Former Task Force member; current member during the writing effort.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.26325DOI Listing
May 2016

Diabetes Mellitus and Prevention of Late Myocardial Infarction After Coronary Stenting in the Randomized Dual Antiplatelet Therapy Study.

Circulation 2016 May 18;133(18):1772-82. Epub 2016 Mar 18.

From Monash Heart and Monash University, Melbourne, Australia (I.T.M., W.-H.H.); Montreal Heart Institute, Université de Montréal, Québec, Canada (J.-F.T.); The Christ Hospital Heart and Vascular Center and The Lindner Center for Research and Education, Cincinnati, OH (D.J.K.); Beth Israel Deaconess Medical Center, Boston, MA (D.E.C.); Harvard Clinical Research Institute, Boston, MA (D.E.C., R.W.Y., J.M.M., L.M.); Harvard Medical School, Boston, MA (D.E.C., R.W.Y., L.M.); The Smith Center for Outcomes Research in Cardiology, Beth Israel Deaconess Medical Center, Boston, MA (R.W.Y.); Lenox Hill Hospital, New York, NY (K.N.G.); Stanford University, Stanford, CA (D.P.L.); Université Paris-Diderot, INSERM U-1148, Hôpital Bichat, Département Hospitalo-Universitaire Fibrosis, Inflammation, and Remodeling, Assistance Publique-Hôpitaux de Paris - all in Paris, National Heart and Lung Institute, Imperial College, Royal Brompton Hospital, London, United Kingdom (P.G.S.); Henry Ford Medical Group, Detroit, MI (W.D.W.); Mayo Clinic, Rochester, MN (D.R.H.); Institute for Health Policy Studies, University of California, San Francisco (R.G.B.); Jan Pawel II Hospital Krakow, Poland (J.T.); Boston University School of Public Health, Boston, MA (J.M.M.); and Brigham and Women's Hospital, Boston, MA (L.M.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.115.016783DOI Listing
May 2016

DAPT Score Utility for Risk Prediction in Patients With or Without Previous Myocardial Infarction.

J Am Coll Cardiol 2016 May 1;67(21):2492-502. Epub 2016 Apr 1.

Harvard Medical School, Boston, Massachusetts; Harvard Clinical Research Institute, Boston, Massachusetts; Department of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacc.2016.03.485DOI Listing
May 2016

Effectiveness of Arterial Closure Devices for Preventing Complications With Percutaneous Coronary Intervention: An Instrumental Variable Analysis.

Circ Cardiovasc Interv 2016 Apr;9(4):e003464

From the Division of Cardiology, Department of Medicine, Christiana Care Health System, Newark, DE (N.J.W.); Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Boston (E.A.S.); Division of Cardiology, Department of Medicine, Brigham and Women's Hospital, Boston, MA (L.M.); Duke Clinical Research Institute, Duke University Medical Center, Durham, NC (M.T.R., D.D.); Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, CA (P.S.-C.); Division of Cardiology, Department of Medicine, University of Washington, Seattle (J.M.M.); Division of Cardiology, Department of Medicine, Lahey Clinic, Burlington, MA (F.S.R.); Division of Cardiology, Department of Medicine, University of Michigan, Ann Arbor (H.S.G.); and Smith Center for Outcomes Research in Cardiology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA (R.W.Y.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCINTERVENTIONS.115.003464DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4832135PMC
April 2016

Predicting Outcomes in Individual Patients After Transcatheter Aortic Valve Replacement: Small Steps on the Path to Improved Decision Making.

JAMA Cardiol 2016 04;1(1):53-4

Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamacardio.2016.0006DOI Listing
April 2016

2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention and the 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Society for Cardiovascular Angiography and Interventions.

Circulation 2016 Mar 21;133(11):1135-47. Epub 2015 Oct 21.

Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry may apply; see Appendixes 1 and 2 for detailed information. ACC/AHA Representative. SCAI Representative. ACC/AHA Task Force on Clinical Practice Guidelines Liaison. Dr. Deborah D. Ascheim accepted a position at Capricor Therapeutics in August 2015, after the writing effort was completed. In accordance with ACC/AHA policy, she recused herself from the final voting process. ACP Representative. ACEP Representative. Former Task Force member; current member during the writing effort.

View Article

Download full-text PDF

Source
https://circ.ahajournals.org/content/early/2015/10/20/CIR.00
Web Search
https://professional.heart.org/idc/groups/ahamah-public/@wcm
Web Search
http://resource.heartonline.cn/2048/primarypciupdate_0FyvCpM
Web Search
http://circ.ahajournals.org/lookup/doi/10.1161/CIR.000000000
Publisher Site
http://dx.doi.org/10.1161/CIR.0000000000000336DOI Listing
March 2016

Temporal Trends in the Risk Profile of Patients Undergoing Outpatient Percutaneous Coronary Intervention: A Report from the National Cardiovascular Data Registry's CathPCI Registry.

Circ Cardiovasc Interv 2016 Mar;9(3):e003070

From the Duke Clinical Research Institute, Duke University Medical Center, Durham, NC (A.N.V., D.D., T.Y.W., M.T.R., M.R.P., E.D.P., S.V.R.); Department of Cardiovascular Medicine, University of Michigan, Ann Arbor (H.G.); Division of Cardiology, Washington University School of Medicine, St. Louis, MO (A.P.A.); Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora (J.C.M.); Division of Cardiovascular Medicine, Department of Medicine, University of California-San Diego (E.M.); Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (L.M.); Harvard Clinical Research Institute, Boston, MA (L.M.); Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, CT (J.C.); and University of Vermont Cardiovascular Research Institute, Burlington, VT (H.L.D.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCINTERVENTIONS.115.003070DOI Listing
March 2016

Causes of late mortality with dual antiplatelet therapy after coronary stents.

Eur Heart J 2016 Jan 18;37(4):378-85. Epub 2015 Nov 18.

The Christ Hospital Heart and Vascular Center, The Lindner Center for Research and Education, Cincinnati, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/eurheartj/ehv614DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4751218PMC
January 2016

Benefits and Risks of Extended Dual Antiplatelet Therapy After Everolimus-Eluting Stents.

JACC Cardiovasc Interv 2016 Jan;9(2):138-47

Harvard Medical School, Boston, Massachusetts; Harvard Clinical Research Institute, Boston, Massachusetts; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2015.10.001DOI Listing
January 2016

Renal Denervation: Where to Now?

Curr Cardiol Rep 2015 Dec;17(12):116

Division of Cardiovascular Medicine, Brigham and Women's Hospital, 75 Francis Street, Boston, MA, 02132, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11886-015-0675-8
Publisher Site
http://dx.doi.org/10.1007/s11886-015-0675-8DOI Listing
December 2015

Renal denervation for the treatment of hypertension: Making a new start, getting it right.

Catheter Cardiovasc Interv 2015 Nov 11;86(5):855-63. Epub 2015 Jun 11.

Center for Interventional Vascular Therapy, Columbia University Medical Center, New York, NY.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ccd.26028
Publisher Site
http://dx.doi.org/10.1002/ccd.26028DOI Listing
November 2015

Reply: Analysis of Dual Antiplatelet Therapy.

J Am Coll Cardiol 2015 Nov;66(18):2056

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacc.2015.08.855DOI Listing
November 2015

Association of body mass index with mortality and cardiovascular events for patients with coronary artery disease: a systematic review and meta-analysis.

Heart 2015 Oct 29;101(20):1631-8. Epub 2015 May 29.

Brigham and Women's Hospital, Boston, Massachusetts, USA Harvard Medical School, Boston, Massachusetts, USA Harvard Clinical Research Institute, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://heart.bmj.com/content/101/20/1631.full.pdf
Web Search
http://heart.bmj.com/lookup/doi/10.1136/heartjnl-2014-307119
Publisher Site
http://dx.doi.org/10.1136/heartjnl-2014-307119DOI Listing
October 2015

Mortality risk with dual antiplatelet therapy?

Lancet 2015 Oct;386(10003):1533-4

Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Harvard Clinical Research Institute, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(15)00486-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4671290PMC
October 2015

Balancing Long-Term Risks of Ischemic and Bleeding Complications After Percutaneous Coronary Intervention With Drug-Eluting Stents.

Am J Cardiol 2015 Sep 3;116(5):686-93. Epub 2015 Jun 3.

Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjcard.2015.05.036DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4670082PMC
September 2015

Enhancing the Prediction of 30-Day Readmission After Percutaneous Coronary Intervention Using Data Extracted by Querying of the Electronic Health Record.

Circ Cardiovasc Qual Outcomes 2015 Sep 18;8(5):477-85. Epub 2015 Aug 18.

From the Cardiology Division, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston (J.H.W., C.O'B., D.M.B., R.W.Y.), Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (L.M.), Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston (G.S.), Cardiovascular Division, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA (J.B.S.), Saint Luke's Mid America Heart Institute/UMKC, Kansas City, MO (K.F.K., J.A.S.); and Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA (S.-L.T.N.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCOUTCOMES.115.001855DOI Listing
September 2015

Renal Denervation for the Treatment of Hypertension: Making a New Start, Getting It Right.

Clin Cardiol 2015 Aug 27;38(8):447-54. Epub 2015 Jul 27.

Center for Interventional Vascular Therapy, Columbia University Medical Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/clc.22424DOI Listing
August 2015

Dual antiplatelet therapy duration and mortality - Authors' reply.

Lancet 2015 May;385(9983):2149-50

Harvard Clinical Research Institute, Boston, MA, USA; Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(15)61019-4DOI Listing
May 2015